» Articles » PMID: 36991216

Multimodal Deep Learning to Predict Prognosis in Adult and Pediatric Brain Tumors

Overview
Publisher Nature Portfolio
Specialty General Medicine
Date 2023 Mar 29
PMID 36991216
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The introduction of deep learning in both imaging and genomics has significantly advanced the analysis of biomedical data. For complex diseases such as cancer, different data modalities may reveal different disease characteristics, and the integration of imaging with genomic data has the potential to unravel additional information than when using these data sources in isolation. Here, we propose a DL framework that combines these two modalities with the aim to predict brain tumor prognosis.

Methods: Using two separate glioma cohorts of 783 adults and 305 pediatric patients we developed a DL framework that can fuse histopathology images with gene expression profiles. Three strategies for data fusion were implemented and compared: early, late, and joint fusion. Additional validation of the adult glioma models was done on an independent cohort of 97 adult patients.

Results: Here we show that the developed multimodal data models achieve better prediction results compared to the single data models, but also lead to the identification of more relevant biological pathways. When testing our adult models on a third brain tumor dataset, we show our multimodal framework is able to generalize and performs better on new data from different cohorts. Leveraging the concept of transfer learning, we demonstrate how our pediatric multimodal models can be used to predict prognosis for two more rare (less available samples) pediatric brain tumors.

Conclusions: Our study illustrates that a multimodal data fusion approach can be successfully implemented and customized to model clinical outcome of adult and pediatric brain tumors.

Citing Articles

Machine learning methods for histopathological image analysis: Updates in 2024.

Komura D, Ochi M, Ishikawa S Comput Struct Biotechnol J. 2025; 27:383-400.

PMID: 39897057 PMC: 11786909. DOI: 10.1016/j.csbj.2024.12.033.


IDH-mutant glioma risk stratification via whole slide images: Identifying pathological feature associations.

Wang X, Wang Z, Wang W, Liu Z, Ma Z, Guo Y iScience. 2025; 28(1):111605.

PMID: 39845415 PMC: 11751506. DOI: 10.1016/j.isci.2024.111605.


Multimodality Fusion Aspects of Medical Diagnosis: A Comprehensive Review.

Kumar S, Rani S, Sharma S, Min H Bioengineering (Basel). 2025; 11(12.

PMID: 39768051 PMC: 11672922. DOI: 10.3390/bioengineering11121233.


A review of deep learning for brain tumor analysis in MRI.

Dorfner F, Patel J, Kalpathy-Cramer J, Gerstner E, Bridge C NPJ Precis Oncol. 2025; 9(1):2.

PMID: 39753730 PMC: 11698745. DOI: 10.1038/s41698-024-00789-2.


Computer Vision in Digital Neuropathology.

Cong C, Liu S, Ieva A, Russo C, Suero Molina E, Pagnucco M Adv Exp Med Biol. 2024; 1462:123-138.

PMID: 39523263 DOI: 10.1007/978-3-031-64892-2_8.


References
1.
Pozo K, Bibb J . The Emerging Role of Cdk5 in Cancer. Trends Cancer. 2016; 2(10):606-618. PMC: 5132345. DOI: 10.1016/j.trecan.2016.09.001. View

2.
Harrell Jr F, Califf R, Pryor D, Lee K, Rosati R . Evaluating the yield of medical tests. JAMA. 1982; 247(18):2543-6. View

3.
Goode A, Gilbert B, Harkes J, Jukic D, Satyanarayanan M . OpenSlide: A vendor-neutral software foundation for digital pathology. J Pathol Inform. 2013; 4:27. PMC: 3815078. DOI: 10.4103/2153-3539.119005. View

4.
Vladimirova V, Waha A, Luckerath K, Pesheva P, Probstmeier R . Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res. 2008; 86(11):2450-61. DOI: 10.1002/jnr.21686. View

5.
Funakoshi Y, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y . Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment. Cancers (Basel). 2021; 13(4). PMC: 7918156. DOI: 10.3390/cancers13040758. View